title: Osseous Metastases in Gynaecological Epithelial Malignancies: A Retrospective Institutional Study and Review of Literature.
abstract: BACKGROUND
  Osseous metastasis in gynaecological epithelial tumours is an extremely rare phenomenon occurring in less than 1% of these cancers.
  
  
  OBJECTIVE
  To analyse the clinical characteristics and prognosis in patients with gynaecological epithelial cancers with bone metastases.
  
  
  METHODS
  This was a single institutional retrospective study done with the data available from January 2008 to January 2015. Out of 1686 patients with epithelial gynaecological malignancies there were a total 18 (1.07%) patients with osseous metastasis. Clinico-pathologic characteristics were tabulated in Microsoft Excel 2013 and data were analysed using SPSS software Version 21. A p-value< 0.05 was taken to be statistically significant. Survival analysis was done by using Kaplan-Meier method and log-rank test was used to find out the difference in survivals.
  
  
  RESULTS
  Out of the 18 gynaecological epithelial cancer patients with bone metastases, 12 had cervical cancer, three had ovarian cancer, two had endometrial carcinoma and one patient had vulvar malignancy. Twelve patients had squamous cell histology, while the rest had adenocarcinoma. The mean interval from primary diagnosis of cancer to the detection of bone metastases was 31.9 months (range, 1 - 60 months). Solitary bone lesion was present in seven patients. The most common site of bone metastasis was lumbar vertebra. Extra-osseous metastasis was present in 12 patients. The mean follow-up period was 8.3 months. During the follow-up period 12 out of the 18 patients died. There was significant difference in survival (p = 0.005) between patients with solitary bone metastasis and patients with multiple osseous metastases. Near significant survival difference (p = 0.056) was also noted in patients with extra-osseous metastases when compared to the patients without. Improved survival was also found in patients with controlled local disease (p = 0.003) when compared to patients with local failure.
  
  
  CONCLUSIONS
  Bone metastasis in gynaecological epithelial malignancies is a rare phenomenon, but with grave prognosis. Multiple sites of bone involvement, recurrence at the primary tumour site and presence of other non-osseous metastases are poor prognostic indicators. Treatment in these patients should be tailored according to the patient's need.
authors.affiliation: Senior Resident, Department of Radiation Oncology, GSL Cancer Hospital, GSL Medical College , Andhra Pradesh, India .
authors.forename: Saptarshi
authors.initials: S
authors.lastname: Ghosh
authors.affiliation: Associate Professor, Department of Radiation Oncology, GSL Cancer Hospital, GSL Medical College , Andhra Pradesh, India .
authors.forename: Pamidimukkala Bramhananda
authors.initials: PB
authors.lastname: Rao
keywords: Bone metastases; Epithelial tumours; Prognostic indicators
references.citation: Int J Gynecol Cancer. 2003 Mar-Apr;13(2):125-9
references.pmid: 12657111
references.citation: Chir Narzadow Ruchu Ortop Pol. 2000;65(6):643-9
references.pmid: 11388015
references.citation: J Cancer Res Ther. 2006 Apr-Jun;2(2):79-81
references.pmid: 17998682
references.citation: Int J Gynecol Cancer. 2010 Apr;20(3):373-8
references.pmid: 20375800
references.citation: Eur J Gynaecol Oncol. 2012;33(4):411-3
references.pmid: 23091900
references.citation: Gynecol Oncol. 1990 Nov;39(2):108-14
references.pmid: 2227582
references.citation: J Obstet Gynaecol. 2012 Jan;32(1):81-6
references.pmid: 22185545
references.citation: Crit Rev Eukaryot Gene Expr. 2009;19(1):47-60
references.pmid: 19191756
references.citation: Gynecol Oncol. 1999 Jun;73(3):407-11
references.pmid: 10366468
references.citation: Lancet Oncol. 2002 Aug;3(8):513
references.pmid: 12147438
references.citation: Eur J Gynaecol Oncol. 1997;18(6):492-4
references.pmid: 9443018
references.citation: Gynecol Oncol. 2001 Nov;83(2):400-4
references.pmid: 11606104
references.citation: Gynecol Oncol. 1997 Jan;64(1):54-8
references.pmid: 8995547
references.citation: Lancet Oncol. 2003 Sep;4(9):547
references.pmid: 12965275
references.citation: J Cancer Res Ther. 2007 Jan-Mar;3(1):34-6
references.pmid: 17998717
references.citation: Saudi Med J. 2013 Dec;34(12):1270-3
references.pmid: 24343467